$0.72
-0.01 (-1.97%)
Open$0.76
Previous Close$0.73
Day High$0.76
Day Low$0.71
52W High$3.82
52W Low$0.69
Volume—
Avg Volume407.4K
Market Cap44.43M
P/E Ratio—
EPS$-0.54
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+1,878.5% upside
Current
$0.72
$0.72
Target
$14.16
$14.16
$9.87
$14.16 avg
$18.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.1K | 3.88M | 19.24M |
| Net Income | -19,709,748 | -160,579,998 | -3,136,016 |
| Profit Margin | -33,044.0% | -4,364.5% | -16.3% |
| EBITDA | -20,591,255 | -164,610,909 | -4,591,050 |
| Free Cash Flow | — | — | -2,958,449 |
| Rev Growth | — | -40.3% | -5.9% |
| Debt/Equity | 0.91 | 0.91 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |